BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18471963)

  • 1. BAY 11-7082 induces cell death through NF-kappaB-independent mechanisms in the Ewing's sarcoma family of tumours.
    White DE; Burchill SA
    Cancer Lett; 2008 Sep; 268(2):212-24. PubMed ID: 18471963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death.
    Myatt SS; Redfern CP; Burchill SA
    Clin Cancer Res; 2005 Apr; 11(8):3136-48. PubMed ID: 15837770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.
    Hu X; Janssen WE; Moscinski LC; Bryington M; Dangsupa A; Rezai-Zadeh N; Babbin BA; Zuckerman KS
    Cancer Res; 2001 Aug; 61(16):6290-6. PubMed ID: 11507084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
    Myatt SS; Burchill SA
    Oncogene; 2008 Feb; 27(7):985-96. PubMed ID: 17700534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane synthase suppression induces lung cancer cell apoptosis via inhibiting NF-κB.
    Leung KC; Li MY; Leung BC; Hsin MK; Mok TS; Underwood MJ; Chen GG
    Exp Cell Res; 2010 Dec; 316(20):3468-77. PubMed ID: 20647010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
    Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
    Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.
    Dai Y; Rahmani M; Dent P; Grant S
    Mol Cell Biol; 2005 Jul; 25(13):5429-44. PubMed ID: 15964800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NF-kappaB pathway mediates fenretinide-induced apoptosis in SH-SY5Y neuroblastoma cells.
    Hewson QD; Lovat PE; Corazzari M; Catterall JB; Redfern CP
    Apoptosis; 2005 May; 10(3):493-8. PubMed ID: 15909111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-ketocholesterol induces apoptosis in differentiated PC12 cells via reactive oxygen species-dependent activation of NF-κB and Akt pathways.
    Jang ER; Lee CS
    Neurochem Int; 2011 Jan; 58(1):52-9. PubMed ID: 21035514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B.
    Javelaud D; Besançon F
    Oncogene; 2001 Jul; 20(32):4365-72. PubMed ID: 11466617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours.
    White DE; Burchill SA
    Br J Cancer; 2010 Oct; 103(9):1380-90. PubMed ID: 20877355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of p21Waf1/Cip1 by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in Ewing tumor cells.
    Javelaud D; Wietzerbin J; Delattre O; Besançon F
    Oncogene; 2000 Jan; 19(1):61-8. PubMed ID: 10644980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
    Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
    Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome.
    Strozyk E; Pöppelmann B; Schwarz T; Kulms D
    Oncogene; 2006 Oct; 25(47):6239-51. PubMed ID: 16702954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors.
    Corbetta S; Vicentini L; Ferrero S; Lania A; Mantovani G; Cordella D; Beck-Peccoz P; Spada A
    Endocr Relat Cancer; 2005 Dec; 12(4):929-37. PubMed ID: 16322332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells.
    Domingo-Domènech J; Pippa R; Tápia M; Gascón P; Bachs O; Bosch M
    Breast Cancer Res Treat; 2008 Nov; 112(1):53-62. PubMed ID: 18064564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nuclear factor-kappa B sensitises anterior pituitary cells to tumour necrosis factor-α- and lipopolysaccharide-induced apoptosis.
    Eijo G; Zárate S; Jaita G; Ferraris J; Magri ML; Zaldivar V; Radl D; Boti V; Pisera D; Seilicovich A
    J Neuroendocrinol; 2011 Aug; 23(8):651-9. PubMed ID: 21564349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of NF-kappaB inhibitors Bay 11-7085 and caffeic acid phenethyl ester to Ramos and other human B-lymphoma cell lines.
    Berger N; Ben Bassat H; Klein BY; Laskov R
    Exp Hematol; 2007 Oct; 35(10):1495-509. PubMed ID: 17889719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
    Qin Y; Auh S; Blokh L; Long C; Gagnon I; Hamann KJ
    Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.